Aristeia Capital’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-821,507
Closed -$8.1M 655
2022
Q3
$8.1M Hold
821,507
0.14% 209
2022
Q2
$8.06M Buy
821,507
+27,767
+3% +$272K 0.14% 192
2022
Q1
$7.79M Buy
+793,740
New +$7.74M 0.14% 190

Aristeia Capital's SSAA Position: Q4 2022 in Review

Aristeia Capital sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 821,507 shares — an estimated $8.1M sold.

Aristeia Capital first reported a position in SSAA in Q1 2022 and held it in 3 quarters. The position peaked at $8.1M in Q3 2022. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

  • Aristeia Capital reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Aristeia Capital sold 821,507 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $8.1M.
  • Aristeia Capital first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Aristeia Capital's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $8.1M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on Aristeia Capital's 13F filing for Q4 2022, filed 14 Feb 2023.